High-performance, Multi-Action Coatings-Materials for Complex Applications Antimicrobial,Antibacterial,Antithrombogenic,Hemocompatible,Drug Delivery and more...
Peak performance attracts attention. Predictable performance builds confidence.
Long-term consistency remains one of the most valuable characteristics of any medical technology.
https://t.co/r5Ta4X9YNm
#MedTech#MedicalDevices#BiomedicalEngineering#MedTechInnovation
Surface performance influences every stage of device delivery.
Assist® is engineered to maintain very low friction while supporting coating integrity during navigation.
https://t.co/gcrvPMEJhj
Surface technologies influence more than device performance.
Product Pathway Partnership supports OEMs from feasibility through to scale-up, helping align coating strategy with wider development goals.
https://t.co/MrpthEBVhY
In the latest Innovation News Network PFAS Special Focus, BioInteractions explores why replacing PTFE is no longer just a regulatory consideration - it's an opportunity to rethink performance.
Read the article: https://t.co/Hhf2SrozI7
#PFAS#MedicalDevices#MedTech#Catheters
Managing microbial activity starts at the surface. TridAnt® provides permanent antimicrobial activity at the surface through a single-layer, non-leaching coating.
https://t.co/P1saGKMPaF
#MedTech#InfectionPrevention#MedicalDevices
Haemocompatibility is an ongoing challenge throughout device use.
AstutePlus® is a single-layer coating designed to support stable haemocompatible surface performance over time.
https://t.co/AaqQWhWzGV
#MedTech#CardiovascularDevices#MedicalDevices
Device performance is often measured at deployment. Long-term success depends on how surfaces behave afterwards.
Consistency over time remains a key engineering challenge.
https://t.co/r5Ta4X9YNm
Not every medical device can rely on a standard coating.
Differences in materials, geometry and application often require tailored surface solutions.
Learn more about BioInteractions’ bespoke materials capability.
https://t.co/aL2BDfE1ol
Surface technologies must work in manufacturing as well as in the body.
Integration into existing production pathways is often just as important as biological performance.
https://t.co/4MqU1K0YKi
Blood‑contacting devices rely on stable haemocompatible surfaces.
AstutePlus® is a permanently bound, single‑layer antithrombogenic coating designed to minimise protein adsorption.
https://t.co/YGKQmUiH5a
#MedTech#MedicalDevices
As devices become smaller, surface behaviour matters more. Reduced profiles can amplify friction and interaction forces during deployment.
Stable surface design becomes increasingly important.
https://t.co/r5Ta4X9YNm
#MedTech#MedicalDevices#BiomedicalEngineering
No two medical devices face the same demands, so surface solutions shouldn’t be one-size-fits-all.
We work with OEM teams to develop bespoke materials tailored to precise device performance needs.
Learn more about our bespoke materials approach: https://t.co/aL2BDfE1ol
A device can behave exactly as expected during development - and differently months later. Why?
The interface evolves. Performance isn’t just about initial behaviour. It’s about how the surface stabilises over time. https://t.co/JGHqf5aAqn
#MedTechInnovation#SurfaceScience
Once bacteria adhere, biofilm formation can follow - increasing complexity in long-term device management. TridAnt® is a single-layer, permanently effective, full-spectrum antimicrobial coating engineered to deliver durable surface activity.
https://t.co/P1saGKMPaF
Within moments of implantation, a protein layer forms on a device surface. From that point on, biology interacts with that layer - not the original material.
Small differences early → major long-term effects. Surface behaviour is key.
https://t.co/4MqU1K0YKi
Drug elution controls biology temporarily. Long-term performance returns to the device interface.
AstutePlus® is a permanently bound, single-layer antithrombogenic coating designed for sustained haemocompatibility.
https://t.co/AaqQWhWzGV
#MedTech#MedicalDevices#Biomaterials
Test models are improving.
But long-term prediction doesn’t always follow. Why? Because once implanted, biology reshapes the surface.
Initial performance ≠ long-term outcome.
Surface stability over time is becoming a key design factor.
https://t.co/4MqU1K0YKi
#MedTech
Our Commercial Director Arjun Luthra recently spoke with MedTech Unboxed’s Steve Maxson about how advanced surface technologies are helping solve these challenges.
Watch the full conversation:
https://t.co/3mTW7xXpsK
#MedTech#MedicalDevices
Not every device fits a standard solution.
BioInteractions develops bespoke single-layer coatings, transforming surfaces to meet specific clinical, mechanical and material needs.
https://t.co/OkK6wCoysa
#MedicalDevices#MedicalCoatings